Comparison of long-term outcomes of infliximab with adalimumab in biologic naïve patients with Crohn\u2019s disease: a tertiary referral center 13-year experience


Creative Commons License

Yüksel İ., Durak M. B., Kılınç V., Kıvrakoğlu F., Koşar K., Erdoğan Ç., ...More

16th Congress of ECCO - European Crohn's and Colitis Organisation, 2 - 10 July 2021, vol.15, no.563, pp.525-526, (Summary Text) identifier